Exelixis

• 1/26/2025

  Cancer Breakthrough: EXEL Leads the Charge

• 1/16/2025

  Biotech Boom: 5 Trends to Watch in 2025

• 12/23/2024

  Trump’s Impact: Top Biotech Stocks to Buy Amid Industry Uncertainty

• 10/21/2024

  Exelixis’ Cabometyx Leads the Charge as Pipeline Assets Near Critical Milestones